The Viral Hemorrhagic Fever Consortium is a partnership of international research institutions investigating Ebola and Lassa. Our mission is to promote global health and safety by creating new products to diagnose, treat, and significantly reduce the incidence and mortality of viral hemorrhagic fevers.

ResearchAbout

Latest News & Publications

Two VHFC articles out in Cell

Two studies by VHFC researchers were published in the August 8 edition of the journal Cell. One study, led by Erica Saphire, defines antibody residues that allow potent and broad neutralizing activity of Lassa virus in a set of three neutralizing...

Simbirie Jalloh wins 2019 African Achievers Award

Congratulations to our KGH Program Manager Ms. Simbirie Jalloh who recently received the 2019 African Achievers Award for excellence in humanitarian service. She has worked for the Lassa fever project at Kenema Government Hospital since 2008 and was honored for her...

Christian Happi wins 2019 HUGO African Prize

The Human Genome Organization (HUGO) has conferred its 2019 HUGO African Prize award to VHFC researcher Prof. Christian Happi, who is professor of Molecular Biology and Director at Redeemer’s University and Director of the World Bank funded African Center of...